249 related articles for article (PubMed ID: 24947929)
1. PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma.
Shah N; Wang J; Selich-Anderson J; Graham G; Siddiqui H; Li X; Khan J; Toretsky J
Clin Cancer Res; 2014 Aug; 20(16):4400-12. PubMed ID: 24947929
[TBL] [Abstract][Full Text] [Related]
2. Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells.
Ferrari-Toninelli G; Bonini SA; Uberti D; Buizza L; Bettinsoli P; Poliani PL; Facchetti F; Memo M
Neuro Oncol; 2010 Dec; 12(12):1231-43. PubMed ID: 20716592
[TBL] [Abstract][Full Text] [Related]
3. Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.
Dobrotkova V; Chlapek P; Jezova M; Adamkova K; Mazanek P; Sterba J; Veselska R
PLoS One; 2019; 14(6):e0218269. PubMed ID: 31188873
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.
Duffy DJ; Krstic A; Halasz M; Schwarzl T; Konietzny A; Iljin K; Higgins DG; Kolch W
Genome Med; 2017 Feb; 9(1):15. PubMed ID: 28187790
[TBL] [Abstract][Full Text] [Related]
5. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
6. Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.
Sonawane P; Cho HE; Tagde A; Verlekar D; Yu AL; Reynolds CP; Kang MH
Br J Pharmacol; 2014 Dec; 171(23):5330-44. PubMed ID: 25039756
[TBL] [Abstract][Full Text] [Related]
7. PBX1 and MEIS1 up-regulate SOX3 gene expression by direct interaction with a consensus binding site within the basal promoter region.
Mojsin M; Stevanovic M
Biochem J; 2009 Dec; 425(1):107-16. PubMed ID: 19799567
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
9. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
10. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
[TBL] [Abstract][Full Text] [Related]
11. Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid.
Yuza Y; Agawa M; Matsuzaki M; Yamada H; Urashima M
J Pediatr Hematol Oncol; 2003 Sep; 25(9):715-20. PubMed ID: 12972807
[TBL] [Abstract][Full Text] [Related]
12. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
[TBL] [Abstract][Full Text] [Related]
13. Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites.
Thiaville MM; Stoeck A; Chen L; Wu RC; Magnani L; Oidtman J; Shih IeM; Lupien M; Wang TL
PLoS One; 2012; 7(5):e36054. PubMed ID: 22567123
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
15. MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.
Wei SJ; Nguyen TH; Yang IH; Mook DG; Makena MR; Verlekar D; Hindle A; Martinez GM; Yang S; Shimada H; Reynolds CP; Kang MH
Cell Death Dis; 2020 May; 11(5):368. PubMed ID: 32409685
[TBL] [Abstract][Full Text] [Related]
16. Shc family expression in neuroblastoma: high expression of shcC is associated with a poor prognosis in advanced neuroblastoma.
Terui E; Matsunaga T; Yoshida H; Kouchi K; Kuroda H; Hishiki T; Saito T; Yamada S; Shirasawa H; Ohnuma N
Clin Cancer Res; 2005 May; 11(9):3280-7. PubMed ID: 15867224
[TBL] [Abstract][Full Text] [Related]
17. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis.
Kato C; Miyazaki K; Nakagawa A; Ohira M; Nakamura Y; Ozaki T; Imai T; Nakagawara A
Int J Cancer; 2004 Nov; 112(3):365-75. PubMed ID: 15382060
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
[TBL] [Abstract][Full Text] [Related]
19. PHOX2B Is Associated with Neuroblastoma Cell Differentiation.
Yang L; Ke XX; Xuan F; Tan J; Hou J; Wang M; Cui H; Zhang Y
Cancer Biother Radiopharm; 2016 Mar; 31(2):44-51. PubMed ID: 26910576
[TBL] [Abstract][Full Text] [Related]
20. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
